...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Re: The chart set up looks awesome imo....

Just one final thought before I hit the sack, with regards to your comment that:"it is all resting on the science at the moment".

I don't disagree, but the scientific data related to the BETonMACE cognition data is already known at this point. It simply hasn't been announced to the market yet.  Its like after an election, where all the ballots have been counted and the results are fixed, but havne't yet been announced.  

The company has already put out a PR stating right up front that Apabetalone improves cognition in CVD patients with diabetes.  All we're waitng to find out at this point is how much improvement, and how the market will react to the news.

My read of the chart has me expecting a very positive reaction.  

Share
New Message
Please login to post a reply